Fig. 3.
Efficacy comparison of cisplatin combined with IL-2 versus cisplatin alone by thoracic injection for controlling MPE. a Thoracic injection of cisplatin alone had a higher NRR compared with cisplatin combined with IL-2 (p < 0.001). b Thoracic injection of cisplatin combined with IL-2 had a higher QOL compared with cisplatin alone (p < 0.001); NRR, non-response rate; QOL, quality of life; OR, odds ratio